Interleukin-2: old and new approaches to enhance immune-therapeutic efficacy
P Dhupkar, N Gordon - Immunotherapy, 2017 - Springer
… efficacy of single-agent aerosol IL-2 and combination therapy aerosol IL-2 and NK cells or
aerosol IL-2 and interleukin 11 … therapy trials using this less invasive and less toxic approach. …
aerosol IL-2 and interleukin 11 … therapy trials using this less invasive and less toxic approach. …
… of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non–muscle-invasive bladder …
RL Steinberg, KG Nepple, KN Velaer… - … Oncology: Seminars and …, 2017 - Elsevier
… We hypothesized that further immunostimulation with intravesical interleukin-2 and
subcutaneous granulocyte-macrophage colony-stimulating factor may improve response to …
subcutaneous granulocyte-macrophage colony-stimulating factor may improve response to …
Outcome and immune correlates of a phase II trial of high-dose interleukin-2 and stereotactic ablative radiotherapy for metastatic renal cell carcinoma
… In conclusion, this prospective phase II single-arm trial showed that SAbR did not improve
the ORR of HD IL2 alone in mRCC patients, but also did not appear to increase toxicities. …
the ORR of HD IL2 alone in mRCC patients, but also did not appear to increase toxicities. …
[HTML][HTML] Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16. F10 melanoma
T Komel, M Bosnjak, SK Brezar, M De Robertis… - …, 2021 - Elsevier
… In conclusion, we demonstrated high antitumour efficacy of combined IL-2 and IL-12 gene
… Interleukin 12 (IL-12), with its potent proinflammatory functions, is a suitable candidate for …
… Interleukin 12 (IL-12), with its potent proinflammatory functions, is a suitable candidate for …
Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12
R Hernandez-Alcoceba, J Poutou… - …, 2016 - Future Medicine
… Phase I evaluation of intravenous recombinant human interleukin 12 in patients with … Phase
I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer …
I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer …
[HTML][HTML] Emerging IL-12 family cytokines in the fight against fungal infections
A Thompson, SJ Orr - Cytokine, 2018 - Elsevier
Invasive fungal infections cause approximately 1.5 million deaths per year worldwide and
are a growing threat to human health. Current anti-fungal therapies are often insufficient, …
are a growing threat to human health. Current anti-fungal therapies are often insufficient, …
… of stage iv triple-negative breast cancer lung metastasis administering low-dose immune checkpoint blockade in combination with hyperthermia and interleukin-2
… fever-range hyperthermia induced by interleukin-2 for 5 days. She went into complete
remission of her pulmonary metastases with transient WHO I-II diarrhea and skin rash. The patient …
remission of her pulmonary metastases with transient WHO I-II diarrhea and skin rash. The patient …
Potential risks related to modulating interleukin-13 and interleukin-4 signalling: a systematic review
M Braddock, NA Hanania, A Sharafkhaneh, G Colice… - Drug Safety, 2018 - Springer
… infections, malignancy or cardiovascular events from therapeutic modulation of the interleukin-13
pathway alone or the combined interleukin-13/… infections, invasive fungal infection or …
pathway alone or the combined interleukin-13/… infections, invasive fungal infection or …
Therapeutic potential of interleukin‑15 in cancer
G Isvoranu, M Surcel… - Experimental and …, 2021 - spandidos-publications.com
… , not only as single therapy, but also in combination with … as a single treatment or in
combination with other therapeutic … to cytokines such as interleukin-2 (IL-2) and interferon-γ (IFNγ…
combination with other therapeutic … to cytokines such as interleukin-2 (IL-2) and interferon-γ (IFNγ…
[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …
KL Winthrop, X Mariette, JT Silva, E Benamu… - … and Infection, 2018 - Elsevier
… Expected impact on the infection risk Eosinophilia is a distinctive feature of some parasitic
infections, particularly those produced by tissue-invasive helminths (such as Schistosoma spp.…
infections, particularly those produced by tissue-invasive helminths (such as Schistosoma spp.…